Variant report
Variant | nsv523998 |
---|---|
Chromosome Location | chr20:23405281-23406519 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:9)
- CpG islands (count:61)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:9 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr20:23406102-23406401 | K562 | blood: | n/a | chr20:23406242-23406253 chr20:23406243-23406252 chr20:23406241-23406252 |
2 | CEBPB | chr20:23406057-23406338 | HepG2 | liver: | n/a | chr20:23406242-23406253 chr20:23406243-23406252 chr20:23406241-23406252 |
3 | GTF2F1 | chr20:23405936-23406103 | H1-hESC | embryonic stem cell: | n/a | n/a |
4 | MAX | chr20:23405980-23406130 | HepG2 | liver: | n/a | n/a |
5 | MYC | chr20:23405967-23405989 | MCF-7 | breast: | n/a | n/a |
6 | MYC | chr20:23405998-23406064 | MCF-7 | breast: | n/a | n/a |
7 | POLR2A | chr20:23405948-23406077 | MCF-7 | breast: | n/a | n/a |
8 | POLR2A | chr20:23405947-23406092 | MCF-7 | breast: | n/a | n/a |
9 | SETDB1 | chr20:23405968-23406910 | U2OS | brain: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr20:23405592-23405642 | AoSMC | blood vessel: | n/a |
2 | chr20:23405592-23405642 | HCT-116 | colon: | n/a |
3 | chr20:23405592-23405642 | A549 | lung: | n/a |
4 | chr20:23405592-23405642 | SK-N-MC | brain: | n/a |
5 | chr20:23405592-23405642 | IMR90 | lung: | fetal |
6 | chr20:23405592-23405642 | Hepatocyte | liver: | n/a |
7 | chr20:23405592-23405642 | MCF-7 | breast: | n/a |
8 | chr20:23405592-23405642 | SK-N-SH_RA | brain: | n/a |
9 | chr20:23405592-23405642 | HepG2 | liver: | n/a |
10 | chr20:23405592-23405642 | U87 | brain: | n/a |
11 | chr20:23405592-23405642 | HCM | heart: | n/a |
12 | chr20:23405592-23405642 | HCPEpiC | choroid plexus: | n/a |
13 | chr20:23405592-23405642 | HMEC | breast: | n/a |
14 | chr20:23405592-23405642 | ProgFib | skin: | n/a |
15 | chr20:23405592-23405642 | AG10803 | skin: | n/a |
16 | chr20:23405592-23405642 | Jurkat | blood: | n/a |
17 | chr20:23405592-23405642 | NHBE | bronchial: | n/a |
18 | chr20:23405592-23405642 | AG04449 | skin: | fetal |
19 | chr20:23405592-23405642 | GM12892 | blood: | n/a |
20 | chr20:23405592-23405642 | AG09309 | skin: | n/a |
21 | chr20:23405592-23405642 | Caco-2 | colon: | n/a |
22 | chr20:23405592-23405642 | AG09319 | gingival: | n/a |
23 | chr20:23405592-23405642 | HIPEpiC | eye: | n/a |
24 | chr20:23405592-23405642 | PANC-1 | pancreas: | n/a |
25 | chr20:23405592-23405642 | HPAEpiC | pulmonary alveolar: | n/a |
26 | chr20:23405592-23405642 | CMK | blood: | n/a |
27 | chr20:23405592-23405642 | NH-A | brain: | n/a |
28 | chr20:23405592-23405642 | SKMC | muscle: | n/a |
29 | chr20:23405592-23405642 | HNPCEpiC | eye: | n/a |
30 | chr20:23405592-23405642 | RPTEC | kidney: | n/a |
31 | chr20:23405592-23405642 | NT2-D1 | testis: | n/a |
32 | chr20:23405592-23405642 | K562 | blood: | n/a |
33 | chr20:23405592-23405642 | HUVEC | blood vessel: | n/a |
34 | chr20:23405592-23405642 | HRE | kidney: | n/a |
35 | chr20:23405592-23405642 | LNCaP | prostate: | n/a |
36 | chr20:23405592-23405642 | Hela-S3 | cervix: | n/a |
37 | chr20:23405592-23405642 | GM19239 | blood: | n/a |
38 | chr20:23405592-23405642 | HRPEpiC | eye: | n/a |
39 | chr20:23405592-23405642 | SK-N-SH | brain: | n/a |
40 | chr20:23405592-23405642 | HAEpiC | amniotic membrane: | n/a |
41 | chr20:23405592-23405642 | GM12891 | blood: | n/a |
42 | chr20:23405592-23405642 | T-47D | breast: | n/a |
43 | chr20:23405592-23405642 | BE2_C | brain: | n/a |
44 | chr20:23405592-23405642 | HEK293 | kidney: | embryo |
45 | chr20:23405592-23405642 | GM12878 | blood: | n/a |
46 | chr20:23405592-23405642 | BJ | skin: | n/a |
47 | chr20:23405592-23405642 | PrEC | prostate: | n/a |
48 | chr20:23405592-23405642 | GM06990 | blood: | n/a |
49 | chr20:23405592-23405642 | PFSK-1 | brain: | n/a |
50 | chr20:23405592-23405642 | MCF10A-Er-Src | breast: | n/a |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr20:23400281..23403754-chr20:23404807..23406566,3 | MCF-7 | breast: | |
2 | chr20:23402152..23403758-chr20:23404630..23407146,2 | K562 | blood: | |
3 | chr20:23400058..23403758-chr20:23404517..23407833,5 | K562 | blood: | |
4 | chr20:23340954..23342681-chr20:23403293..23405458,3 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
NAPB | TF binding region |
NAPB | CpG island |
ENSG00000125814 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2180139 | chr20:23405281-23405282 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs185840097 | chr20:23405319-23405320 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs189486853 | chr20:23405320-23405321 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs577674807 | chr20:23405350-23405351 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs543428698 | chr20:23405426-23405427 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs376871044 | chr20:23405454-23405455 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs557026220 | chr20:23405479-23405480 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs200753780 | chr20:23405492-23405493 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs3040403 | chr20:23405493-23405494 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs200801863 | chr20:23405494-23405495 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs542992349 | chr20:23405515-23405516 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs559859137 | chr20:23405551-23405552 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs73610703 | chr20:23405564-23405565 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs528682010 | chr20:23405593-23405594 | Weak transcription Enhancers | CpG islandChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs77908916 | chr20:23405626-23405627 | Weak transcription ZNF genes & repeats Enhancers Flanking Active TSS | CpG islandChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs565022438 | chr20:23405634-23405635 | Weak transcription ZNF genes & repeats Enhancers Flanking Active TSS | CpG islandChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs139871748 | chr20:23405639-23405640 | Weak transcription ZNF genes & repeats Enhancers Flanking Active TSS | CpG islandChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs550556943 | chr20:23405644-23405645 | Weak transcription ZNF genes & repeats Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs567592374 | chr20:23405660-23405661 | Weak transcription ZNF genes & repeats Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs78050888 | chr20:23405682-23405683 | Weak transcription ZNF genes & repeats Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs143328970 | chr20:23405687-23405688 | Weak transcription ZNF genes & repeats Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs565837271 | chr20:23405691-23405692 | Weak transcription ZNF genes & repeats Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs150775388 | chr20:23405692-23405693 | Weak transcription ZNF genes & repeats Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs373687665 | chr20:23405768-23405769 | Weak transcription ZNF genes & repeats Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs77850737 | chr20:23405796-23405797 | Weak transcription ZNF genes & repeats Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs181475556 | chr20:23405806-23405807 | ZNF genes & repeats Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs186167741 | chr20:23405828-23405829 | ZNF genes & repeats Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs376368955 | chr20:23405844-23405845 | ZNF genes & repeats Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs573565958 | chr20:23405880-23405881 | ZNF genes & repeats Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs76923026 | chr20:23405890-23405891 | ZNF genes & repeats Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs78916169 | chr20:23405904-23405905 | ZNF genes & repeats Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs190145041 | chr20:23405922-23405923 | ZNF genes & repeats Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs545174998 | chr20:23405932-23405933 | ZNF genes & repeats Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs139190453 | chr20:23405955-23405956 | ZNF genes & repeats Weak transcription Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs575324549 | chr20:23406015-23406016 | ZNF genes & repeats Bivalent Enhancer Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs556421637 | chr20:23406016-23406017 | ZNF genes & repeats Bivalent Enhancer Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs114738764 | chr20:23406054-23406055 | ZNF genes & repeats Bivalent Enhancer Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs530059942 | chr20:23406059-23406060 | ZNF genes & repeats Bivalent Enhancer Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs549223133 | chr20:23406091-23406092 | ZNF genes & repeats Bivalent Enhancer Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs149964131 | chr20:23406103-23406104 | ZNF genes & repeats Bivalent Enhancer Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs528426057 | chr20:23406104-23406105 | ZNF genes & repeats Bivalent Enhancer Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs6137945 | chr20:23406136-23406137 | ZNF genes & repeats Bivalent Enhancer Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
43 | rs59852988 | chr20:23406137-23406138 | ZNF genes & repeats Bivalent Enhancer Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
44 | rs561529520 | chr20:23406194-23406195 | ZNF genes & repeats Bivalent Enhancer Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs201845334 | chr20:23406256-23406257 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs138141994 | chr20:23406259-23406260 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs554311257 | chr20:23406263-23406264 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs145191428 | chr20:23406303-23406304 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs80028511 | chr20:23406332-23406333 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs535885667 | chr20:23406356-23406357 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 16272173 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 19627613 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Colorectal cancer | 21645411 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Alagille syndrome | 17576883 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Cancer | 21183584 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Breast cancer | 16608533 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Breast cancer | 17133270 | CNVD |
Thrombophilia | 17576883 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 21062444 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Chordoma | 18071362 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
small cell lung cancer | 17426248 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:23402400-23406000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr20:23402600-23405600 | Enhancers | Primary T cells from cord blood | blood |
3 | chr20:23402600-23405600 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
4 | chr20:23402600-23405800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
5 | chr20:23402600-23405800 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
6 | chr20:23402600-23406000 | Weak transcription | NHEK | skin |
7 | chr20:23402800-23405600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
8 | chr20:23403200-23406200 | Enhancers | Fetal Thymus | thymus |
9 | chr20:23405200-23405600 | Enhancers | HepG2 | liver |
10 | chr20:23405600-23406200 | ZNF genes & repeats | iPS-15b Cell Line | embryonic stem cell |
11 | chr20:23405600-23406200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
12 | chr20:23405600-23406200 | Flanking Active TSS | HepG2 | liver |
13 | chr20:23405800-23406200 | ZNF genes & repeats | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
14 | chr20:23405800-23406200 | ZNF genes & repeats | iPS DF 6.9 Cell Line | embryonic stem cell |
15 | chr20:23406000-23406200 | Bivalent Enhancer | H1 Derived Mesenchymal Stem Cells | ES cell derived |
16 | chr20:23406000-23406200 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
17 | chr20:23406000-23406600 | Enhancers | NHEK | skin |
18 | chr20:23406200-23406400 | Enhancers | HepG2 | liver |